Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1David A. Barbie, William C. Hahn, Susan E. Moody et al.|Nature|2009Cited by 4.2k
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancerMartin L. Sos, Roman K. Thomas, Stefanie Fischer et al.|Proceedings of the National Academy of Sciences|2009Cited by 255